MSCV-(pBabe mcs)- human p210BCR-ABL-IRES-GFP Citations (2)

Originally described in: Roussel lab plasmids
Unpublished

Articles Citing MSCV-(pBabe mcs)- human p210BCR-ABL-IRES-GFP

Articles
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations. Yenerall P, Kollipara RK, Avila K, Peyton M, Eide CA, Bottomly D, McWeeney SK, Liu Y, Westover KD, Druker BJ, Minna JD, Kittler R. Cancer Res. 2021 Sep 15;81(18):4685-4695. doi: 10.1158/0008-5472.CAN-21-1153. Epub 2021 Jul 23. PubMed
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells. Qian F, Nettleford SK, Zhou J, Arner BE, Hall MA, Sharma A, Annageldiyev C, Rossi RM, Tukaramrao DB, Sarkar D, Hegde S, Gandhi UH, Finch ER, Goodfield L, Quickel MD, Claxton DF, Paulson RF, Prabhu KS. Cell Rep. 2023 Jul 25;42(7):112794. doi: 10.1016/j.celrep.2023.112794. Epub 2023 Jul 18. PubMed Associated Plasmids pLV hU6-sgKRAS hUbC-dCas9-KRAB-T2a-GFP1 pLV hU6-sgKRAS hUbC-dCas9-KRAB-T2a-GFP2

If you have published an article using this material, please email us at [email protected] to have your article added to this page.